Lucid Diagnostics LUCD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$45.01M+22.4% | -$58.01M-8.9% | -$53.29M+3.6% | -$55.26M+10.6% | -$61.83M-35.8% | ||
| $873K+0.1% | $872K-1.5% | $885K+0.6% | $880K-0.8% | $887K-24.0% | ||
| —— | —— | $4.38M-1.1% | $4.43M+0.8% | $4.39M+4.9% | ||
| $631K+5.0% | $601K+17.4% | $512K+140% | $213K+1,675% | $12K— | ||
| —— | —— | —— | —— | -$140K-246% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$684.25K+41.0% | ||
| -$46.12M+0.8% | -$46.49M-6.2% | -$43.78M-1.7% | -$43.06M+2.1% | -$43.99M+0.3% | ||
| —— | —— | —— | —— | $315K+6.4% | ||
| -$319K-61.9% | -$197K+51.4% | -$405K+44.3% | -$727K-3.6% | -$702K-8.7% | ||
| —— | —— | —— | —— | $16.57M-23.3% | ||
| —— | $0-100% | $904K-50.0% | $1.81M-33.3% | $2.71M-25.0% | ||
| $34K+100% | $17K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $49.08M-16.9% | $59.03M-23.4% | $77.03M+54.1% | $49.99M+10.7% | $45.16M-6.4% | ||
| —— | —— | $32.84M+429% | $6.2M+1,223% | $469K-86.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$684.25K+41.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $904K-50.0% | $1.81M-33.3% | $2.71M-25.0% | ||
| —— | —— | —— | —— | $333.5K-3.6% | ||
| —— | —— | —— | —— | -$10.43M-293% | ||
| —— | -$1.08M-33.3% | -$808.5K-50.0% | -$539K-100% | -$269.5K— | ||
| —— | —— | —— | —— | -$45.89M-3.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lucid Diagnostics generate?
- Lucid Diagnostics (LUCD) generated -$46.1M in operating cash flow over the trailing twelve months.
- What is Lucid Diagnostics's free cash flow?
- After $456.0K of capital expenditures, Lucid Diagnostics's free cash flow was -$47.1M over the trailing twelve months, down 40.1% year over year.
- Where does Lucid Diagnostics's cash flow data come from?
- Every line is extracted from Lucid Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
